Platinum small vessel study of PROMUS Element Stent shows long-term safety and ... 
pharmabiz.com
?The PLATINUM Small Vessel data continue to demonstrate very low revascularization rates, with no myocardial infarction or stent thrombosis through two years of follow up in patients treated with the 2.25 mm PROMUS Element Stent,? said Ian Meredith, ...
FDA Approval for BSX Epic Stent Zacks.com
Boston Scientific Gets Approval For New Leg Stent Manufacturing.net
Boston Scientific gets FDA nod for vascular stent Boston Business Journal
PR Newswire (press release) 
all 12 news articles » 

PROMUS Element? Stent Demonstrates Excellent Long-Term Safety and ... 
Sacramento Bee
"The PLATINUM Small Vessel data continue to demonstrate very low revascularization rates, with no myocardial infarction or stent thrombosis through two years of follow up in patients treated with the 2.25 mm PROMUS Element Stent," said Ian Meredith, ...
Boston Scientific Reports 2-yr Results From PLATINUM Small Vessel Study RTT News

all 20 news articles » 

Biodegradable Stents Hold Up 
MedPage Today
A series of studies of new biodegradable drug-eluting stents generally found noninferiority in composite outcomes compared with conventional in-place drug-eluting stents. Note that follow-up periods in these trials are still short.

 

Boston Scientific wins approval for new leg stent 
BusinessWeek
Medical device maker Boston Scientific Corp. said Thursday it received US approval for a new type of stent to treat blocked arteries in the legs. The Food and Drug Administration approved the company's Epic Vascular Self-Expanding stent for iliac ...
Boston Scientific Announces FDA Approval and U.S. Launch of EPIC? Vascular Stent Sacramento Bee
Boston Scientific gets FDA nod, launches Epic stent Mass High Tech
Boston Scientific Announces FDA Approval and U.S. Launch of EPIC(TM) Vascular ... MarketWatch (press release)
Daily Markets 
all 37 news articles » 

'Virtual Stenting' Aids PCI Planning 
MedPage Today
This study suggests that CT-derived computed fractional flow reserve estimation along with CT-derived virtual stent placement can accurately predict the success of intervention in relieving myocardial ischemia. PARIS -- Computer projections of the ...
EuroPCR 2012 press release for Wednesday, May 16, 2012 Phys.Org (press release)

all 7 news articles » 

KEVIN STENT/Fairfax NZ 
Stuff.co.nz
CAPITAL BUSINESS: Garage Project co-founder Peter Gillespie, left, and Jos Ruffell in their new Aro Valley brewery. Peter Gillespie strokes the shining stainless steel of his new mash tun. He's like a boy who has just opened his Christmas presents and ...

and more » 

Xience Stents Gain European Nod For Three-Month Dual Antiplatelet Therapy 
Forbes
The biggest drawback to drug-eluting stents has been the requirement for prolonged dual antiplatelet (DAPT) therapy following stent implantation to prevent stent thrombosis and other potential complications. The precise length of DAPT has been the ...
CIBELES: Xience Stands Up to Cypher for CTO PCI TCTMD

all 3 news articles » 

Early Coronary Artery Healing Advantage of OrbusNeich's Combo Dual Therapy ... 
MarketWatch (press release)
PARIS, May 17, 2012 /PRNewswire via COMTEX/ -- OrbusNeich today announced that two subgroup analyses from the REMEDEE trial assessing vascular healing of the company's Combo Dual Therapy Stent versus the TAXUS paclitaxel-eluting stent demonstrate an ...
OrbusNeich's Combo Dual Therapy Stent? Demonstrates Favorable Clinical and ... PR Newswire (press release)

all 15 news articles » 

Novel Stent Safer in MI 
MedPage Today
This study suggests that this biodegradable polymer drug-eluting stent is superior to bare-metal stents in reducing major adverse cardiac events among STEMI patients at one year. PARIS -- A novel drug-eluting stent appears to substantially improve ...
COMFORTABLE-AMI: Bioerodable polymer DES trumps bare metal in STEMI TheHeart.Org
Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations TCTMD

all 3 news articles » 

Boston Scientific Announces CE Mark and European Launch of Innova(TM) Self ... 
MarketWatch (press release)
NATICK, Mass., May 14, 2012 /PRNewswire via COMTEX/ -- Boston Scientific Corporation (NYSE:BSX) announces CE Mark and European market launch of the Innova(TM) Self-Expanding Bare-Metal Stent System, which is designed to treat peripheral vascular ...
Boston Scientific launches Innova self-expanding bare-metal stent system in ... pharmabiz.com
One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And ... Daily Markets
Boston Scientific Introduces Stent System to Europe Patch.com
Mass Device 
all 32 news articles »